Is bupropion extended‑release (XL) 150 mg appropriate for anxiety, and should the dose be increased to 300 mg?

Bupropion XL is NOT appropriate for treating anxiety as a primary indication

Bupropion XL (150 mg or 300 mg) is not FDA-approved for anxiety disorders and should generally be avoided as a first-line treatment for anxiety. The medication is FDA-approved only for major depressive disorder (MDD) and seasonal affective disorder (SAD), not for anxiety 1.

Key Clinical Considerations

Why Bupropion is Problematic for Anxiety

Bupropion has activating properties that can provoke or worsen anxiety symptoms, particularly at higher doses 2, 3. The FDA label explicitly notes it "should not be used in agitated patients" 2. This is because bupropion works as a norepinephrine and dopamine reuptake inhibitor—a mechanism that tends to be stimulating rather than calming 3.

The Evidence is Mixed but Leans Against Use

While some recent research suggests bupropion may not significantly worsen anxiety in patients with comorbid depression and anxiety 4, 5, the evidence quality is very low certainty 6. The most relevant findings:

• A small pilot trial (n=24) showed bupropion XL had comparable anxiolytic effects to escitalopram in generalized anxiety disorder (GAD), but this was a single small study 7
• Larger analyses suggest SSRIs show a modest advantage over bupropion in patients with high baseline anxiety 4
• In depression with comorbid anxiety, bupropion may improve anxiety symptoms secondarily as depression improves, but this is not the same as treating primary anxiety 3, 4

Dosing Concerns

The FDA-approved dosing for MDD is:

• Start: 150 mg once daily for 4 days
• Target: 300 mg once daily after day 4 1

However, for patients with any anxiety concerns, the activating effects at 300 mg are more pronounced 3. The guideline evidence shows bupropion at 150 mg twice daily (total 300 mg/day) carries warnings about monitoring for "hostility, depression, or suicidal behavior" 8.

Clinical Algorithm for Decision-Making

Do NOT use bupropion XL if:

• Primary diagnosis is an anxiety disorder (GAD, panic disorder, social anxiety)
• Patient has significant baseline agitation or restlessness
• Patient has a seizure disorder (absolute contraindication) 8, 1
• Patient has eating disorders (bulimia/anorexia—higher seizure risk) 6

Consider bupropion XL only if:

• Primary diagnosis is MDD with mild comorbid anxiety symptoms
• Patient has failed or cannot tolerate SSRIs/SNRIs
• Patient specifically needs to avoid sexual side effects common with SSRIs 4
• You start at 150 mg and monitor closely for anxiety worsening before any dose increase

If anxiety worsens on 150 mg: Stop bupropion immediately and switch to an SSRI or SNRI, which have established efficacy for both depression and anxiety 3, 4.

Common Pitfalls to Avoid

1. Don't increase to 300 mg if anxiety is present at baseline—the stimulating effects intensify with higher doses 3
2. Don't confuse improvement in depression-related anxiety with true anxiolytic effects—bupropion may help anxiety secondarily by treating depression, but this doesn't make it appropriate for primary anxiety disorders 3, 4
3. Don't ignore the "activating" warning in the label—this is specifically relevant to anxious patients 2, 1

Bottom Line

For anxiety, choose an SSRI or SNRI instead. If the patient has MDD with mild anxiety and you still want to try bupropion, start at 150 mg XL and do not increase to 300 mg unless anxiety remains stable or improves. Monitor weekly for the first month for any worsening agitation, restlessness, or anxiety symptoms 1, 3.